AI Stock Memo: IEX - IDEX - RankAlpha

IEX

AI Memo

IDEX

As of 2026-04-29/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-04-29 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

—

Key catalyst

Q1 beat with raised 2026 guidance • 2026-04-29

Expected move: -1%

Biggest risk

The quarter was not uniformly strong: FMT organic sales were only +2%, FSDP organic sales were -1%, gross margin fell 40 bps, and free cash flow conversion was only 58% in Q1, so a single HST-led quarter should not be over-extrapolated [#8-K-2026-04-29].

Invalidation

Break below $188 or thesis failure.

What would change my mind?

The earnings release materially improved the near-term setup: record orders, an EPS beat, and a guidance raise support a cautious positive revision to the prior neutral stance, especially with HST benefiting from AI/data-center and semiconductor demand [#8-K-2026-04-29].

Research note

Recommendation

—

Confidence

medium

As of

2026-04-29

Base target

$220

p=50%

Bull target

$232

p=25%

Bear target

$188

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Post-print digestion still has room but revision evidence is thin
HST demand and order momentum can extend the re-rate
The earnings release materially improved the near-term setup: record orders, an EPS beat, and a guidance raise support a cautious positive revision to the prior neutral stance, especially with HST benefiting from AI/data-center and semiconductor demand [#8-K-2026-04-29].

BearKey bullets

Gross margin fell to 44.9% from 45.3% due to unfavorable mix and pressured price/cost, only partly offset by productivity [#8-K-2026-04-29].
Growth is concentrated in HST; FMT and FSDP were much softer, with FSDP organic sales down 1% [#8-K-2026-04-29].
IDEX says it is primarily a short-cycle business and backlog is not generally a significant factor, which limits backlog protection if incoming orders soften [#10-K-2026-02-19].

WatchKey bullets

Q1 beat with raised 2026 guidance

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $220 (p=50%)

Bull/Bear spread: +4% / -15%

Vs latest close: Bull +4% · Base -1% · Bear -15%

Scenario probabilities

Bull Target: $232 (p=25%)Base Target: $220 (p=50%)Bear Target: $188 (p=25%)

Commentary

Headline buzz is high because this is an earnings-day follow-up. Price action was positive but not extreme: IEX traded about 4.9% above the $205.36 anchor on April 29 and below the session high of $224.99. Trusted secondary coverage indicated a meaningful EPS and revenue beat, but T+1 analyst target/rating revision evidence was still sparse, so this remains a moderate-confidence post-earnings monitoring memo rather than a full thesis reset.

As of 2026-04-29 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Post-print digestion still has room but revision evidence is thin
HST demand and order momentum can extend the re-rate

Scenarios

Bull Target (Scenario probability)

$232 / p=25% prob

Base Target (Scenario probability)

$220 / p=50% prob

Bear Target (Scenario probability)

$188 / p=25% prob

Price $222 as of 2026-07-10

Nearest Scenario: Base (∆ 1%)

Targets vs latest close: Bull +4% · Base -1% · Bear -15%

Sentiment & Exposure

News Sentiment (30d)

0.45

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-04-29
Q1 beat with raised 2026 guidance
IDEX reported Q1 sales of $886.9M (+9% reported, +5% organic), adjusted EPS of $2.00, record orders of $988.3M (+13% reported, +10% organic), and raised full-year organic growth guidance to 3%-4% from 1%-2% and adjusted EPS to $8.35-$8.55 from $8.15-$8.35 [#8-K-2026-04-29].
Prob 80.00% • Move 6.00% • Priced-in 70.00%

Short-term Catalysts

Next few weeks

Post-print digestion still has room but revision evidence is thin
2026-05-15
The stock traded at $215.49 on April 29, 2026 versus a $205.36 prior close anchor, a roughly 4.9% gain, while the packet's median analyst target is $226.08; that leaves modest upside if follow-through revisions arrive, but T+1 target/rating changes were not yet clearly available.
Prob 45% • Move 3% • Priced-in 55%

Long-term Catalysts

Months to a year

HST demand and order momentum can extend the re-rate
2026-09-30
Health & Science Technologies grew 17% reported and 11% organically, driven by AI-linked data center power, semiconductor, and space/defense demand, while management said 8020 execution is reallocating resources toward stronger growth and margin opportunities [#8-K-2026-04-29] [#10-K-2026-02-19].
Prob 65% • Move 8% • Priced-in 50%

Risks

Gross margin fell to 44.9% from 45.3% due to unfavorable mix and pressured price/cost, only partly offset by productivity [#8-K-2026-04-29].
Growth is concentrated in HST; FMT and FSDP were much softer, with FSDP organic sales down 1% [#8-K-2026-04-29].
IDEX says it is primarily a short-cycle business and backlog is not generally a significant factor, which limits backlog protection if incoming orders soften [#10-K-2026-02-19].
Operating cash flow and free cash flow were slightly down year over year because of customer payment timing and higher capex, so annual cash conversion still needs to prove out [#8-K-2026-04-29].
Tariffs, trade policy, FX, supply chain conditions, material costs, and broader industrial activity remain explicit risk factors [#10-K-2026-02-19].

Peers

Symbol	Summary
NDSN	Nordson is the closest listed comp on precision dispensing and engineered components; its premium multiple is relevant if IDEX can sustain HST-led organic growth and margin discipline.
LECO	Lincoln Electric offers a useful read-through on industrial demand and operating execution, though its welding exposure is less aligned with IDEX's fluidics and life-science mix.
EMR	Emerson is a broader automation peer; its scale and automation exposure make it a looser comp, but it frames how investors value industrial names with stronger secular demand support.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-04-29